US FDA approves GE HealthCare’s diagnostic drug for the treatment of heart disease
The US Food and Drug Administration has approved a GE HealthCare diagnostic drug for use in detecting coronary heart disease, the company said on Friday.
BELIEBTE BEITRÄGE
Earthquakes and emissions undermine the idea of carbon storage in Texas
Dezember 17, 2024
Rescuers search for cyclone survivors in devastated Mayotte
Dezember 17, 2024
“Gilmore Girls” airs for a second season on Hulu
Dezember 17, 2024
LIVEÜBERTRAGUNG